Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Roulot

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
JHEP Reports : Innovation in Hepatology|May 20, 2026
Progression to cirrhosis in chronic hepatitis D with mild-to-moderate fibrosis: insights from a multicenter European cohortSabela Lens, Habiba Kamal, Arno Furquim d'Almeida, et al.
European Journal of Gastroenterology & Hepatology|April 29, 2024
Hepatitis B Delta: assessment of the knowledge and practices of hepato-gastroenterologists practicing in non-academic settings in FranceJean-François D Cadranel, Honoré T Zougmoré, Jean-René Ngele Efole, et al.
Journal of Medical Virology|October 27, 2009
Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapyFlorence Legrand-Abravanel, Philippe Colson, Hélène Leguillou-Guillemette, et al.
Hepatology (Baltimore, Md.)|September 19, 2021
Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseasesPere Ginès, Laurent Castera, Frank Lammert, et al.
Viruses|April 27, 2026
Delta Describe, the French Collaborative Project: The Profile and Management of Hepatitis Delta Patients in Metropolitan FranceMarie Bosselut, Paul Carrier, Ségolène Brichler, et al.
Journal of Hepatology|February 28, 2025
Value of non-invasive test dynamics in guiding HCC surveillance decisions after HCV cure in patients with cirrhosisPierre Nahon, Clovis Lusivika-Nzinga, Philippe Merle, et al.
JHEP Reports : Innovation in Hepatology|July 24, 2024
Treatment with bulevirtide in HIV-infected patients with chronic hepatitis D: ANRS HD EP01 BuleDelta and compassionate cohortVictor de Lédinghen, Claire Fougerou-Leurent, Estelle Le Pabic, et al.
Journal of Viral Hepatitis|November 1, 2018
Non-virological factors are drivers of hepatocellular carcinoma in virosuppressed hepatitis B cirrhosis: Results of ANRS CO12 CirVir cohortSegolene Brichler, Pierre Nahon, Fabien Zoulim, et al.
Journal of Hepatology|July 3, 2020
Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV statusEtienne Audureau, Fabrice Carrat, Richard Layese, et al.
Gastroenterology|July 22, 2018
Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance ProgramsPierre Nahon, Richard Layese, Valérie Bourcier, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
JHEP Reports : Innovation in Hepatology|May 20, 2026
Progression to cirrhosis in chronic hepatitis D with mild-to-moderate fibrosis: insights from a multicenter European cohortSabela Lens, Habiba Kamal, Arno Furquim d'Almeida, et al.
European Journal of Gastroenterology & Hepatology|April 29, 2024
Hepatitis B Delta: assessment of the knowledge and practices of hepato-gastroenterologists practicing in non-academic settings in FranceJean-François D Cadranel, Honoré T Zougmoré, Jean-René Ngele Efole, et al.
Journal of Medical Virology|October 27, 2009
Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapyFlorence Legrand-Abravanel, Philippe Colson, Hélène Leguillou-Guillemette, et al.
Hepatology (Baltimore, Md.)|September 19, 2021
Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseasesPere Ginès, Laurent Castera, Frank Lammert, et al.
Viruses|April 27, 2026
Delta Describe, the French Collaborative Project: The Profile and Management of Hepatitis Delta Patients in Metropolitan FranceMarie Bosselut, Paul Carrier, Ségolène Brichler, et al.
Journal of Hepatology|February 28, 2025
Value of non-invasive test dynamics in guiding HCC surveillance decisions after HCV cure in patients with cirrhosisPierre Nahon, Clovis Lusivika-Nzinga, Philippe Merle, et al.
JHEP Reports : Innovation in Hepatology|July 24, 2024
Treatment with bulevirtide in HIV-infected patients with chronic hepatitis D: ANRS HD EP01 BuleDelta and compassionate cohortVictor de Lédinghen, Claire Fougerou-Leurent, Estelle Le Pabic, et al.
Journal of Viral Hepatitis|November 1, 2018
Non-virological factors are drivers of hepatocellular carcinoma in virosuppressed hepatitis B cirrhosis: Results of ANRS CO12 CirVir cohortSegolene Brichler, Pierre Nahon, Fabien Zoulim, et al.
Journal of Hepatology|July 3, 2020
Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV statusEtienne Audureau, Fabrice Carrat, Richard Layese, et al.
Gastroenterology|July 22, 2018
Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance ProgramsPierre Nahon, Richard Layese, Valérie Bourcier, et al.
Pageof 8